VEGF-mediated Disruption of Endothelial CLN-5 Promotes Blood-brain Barrier Breakdown

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2009 Jan 29

PMID 19174516

Citations 327

Authors

Azeb Tadesse Argaw

Blake T Gurfein

Yueting Zhang

Andleeb Zameer

Gareth R John

Affiliations

Soon will be listed here.

Abstract

Breakdown of the blood-brain barrier (BBB) is an early and significant event in CNS inflammation. Astrocyte-derived VEGF-A has been implicated in this response, but the underlying mechanisms remain unresolved. Here, we identify the endothelial transmembrane tight junction proteins claudin-5 (CLN-5) and occludin (OCLN) as targets of VEGF-A action. Down-regulation of CLN-5 and OCLN accompanied up-regulation of VEGF-A and correlated with BBB breakdown in experimental autoimmune encephalomyelitis, an animal model of CNS inflammatory disease. In cultures of brain microvascular endothelial cells, VEGF-A specifically down-regulated CLN-5 and OCLN protein and mRNA. In mouse cerebral cortex, microinjection of VEGF-A disrupted CLN-5 and OCLN and induced loss of barrier function. Importantly, functional studies revealed that expression of recombinant CLN-5 protected brain microvascular endothelial cell cultures from a VEGF-induced increase in paracellular permeability, whereas recombinant OCLN expressed under the same promoter was not protective. Previous studies have shown CLN-5 to be a key determinant of trans-endothelial resistance at the BBB. Our findings suggest that its down-regulation by VEGF-A constitutes a significant mechanism in BBB breakdown.

Citing Articles

Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?.

van der Mescht M, Steel H, Anderson R, Rossouw T Front Cell Infect Microbiol. 2025; 14:1458195.

PMID: 40008234 PMC: 11850333. DOI: 10.3389/fcimb.2024.1458195.

The Factors Associated with the Blood-Brain Barrier Dysfunction in Tick-Borne Encephalitis.

Grygorczuk S, Czupryna P, Martonik D, Adamczuk J, Parfieniuk-Kowerda A, Grzeszczuk A Int J Mol Sci. 2025; 26(4).

PMID: 40003967 PMC: 11855613. DOI: 10.3390/ijms26041503.

Tight junction proteins in glial tumors development and progression.

Moskal J, Michalak S Front Cell Neurosci. 2025; 19:1541885.

PMID: 39963115 PMC: 11830821. DOI: 10.3389/fncel.2025.1541885.

The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies.

Wang P, Okada-Rising S, Scultetus A, Bailey Z Biomedicines. 2025; 12(12.

PMID: 39767605 PMC: 11672875. DOI: 10.3390/biomedicines12122698.

Endothelial cells as key players in cerebral small vessel disease.

Kremer R, Williams A, Wardlaw J Nat Rev Neurosci. 2025; 26(3):179-188.

PMID: 39743557 DOI: 10.1038/s41583-024-00892-0.

References

Janzer R, Raff M . Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 1987; 325(6101):253-7. DOI: 10.1038/325253a0. View

Burek M, Forster C . Cloning and characterization of the murine claudin-5 promoter. Mol Cell Endocrinol. 2008; 298(1-2):19-24. DOI: 10.1016/j.mce.2008.09.041. View

Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M . Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007; 13(10):1173-5. PMC: 5114125. DOI: 10.1038/nm1651. View

Matsuda M, Kubo A, Furuse M, Tsukita S . A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells. J Cell Sci. 2004; 117(Pt 7):1247-57. DOI: 10.1242/jcs.00972. View

Abbott N, Ronnback L, Hansson E . Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2005; 7(1):41-53. DOI: 10.1038/nrn1824. View

Lindahl P, Johansson B, Leveen P, Betsholtz C . Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997; 277(5323):242-5. DOI: 10.1126/science.277.5323.242. View

Proescholdt M, Jacobson S, Tresser N, Oldfield E, Merrill M . Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol. 2002; 61(10):914-25. DOI: 10.1093/jnen/61.10.914. View

Song L, Ge S, Pachter J . Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood. 2006; 109(4):1515-23. PMC: 1794065. DOI: 10.1182/blood-2006-07-034009. View

Chen L, Brosnan C . Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes. J Immunol. 2006; 176(5):3115-26. DOI: 10.4049/jimmunol.176.5.3115. View

10.

Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N . Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003; 161(3):653-60. PMC: 2172943. DOI: 10.1083/jcb.200302070. View

11.

Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S . Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993; 123(6 Pt 2):1777-88. PMC: 2290891. DOI: 10.1083/jcb.123.6.1777. View

12.

Argaw A, Zhang Y, Snyder B, Zhao M, Kopp N, Lee S . IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol. 2006; 177(8):5574-84. DOI: 10.4049/jimmunol.177.8.5574. View

13.

Dobrogowska D, Lossinsky A, Tarnawski M, Vorbrodt A . Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol. 2000; 27(3):163-73. DOI: 10.1023/a:1006907608230. View

14.

Bunge R, Bunge M, RISH . Electron microscopic study of demyelination in an experimentally induced lesion in adult cat spinal cord. J Biophys Biochem Cytol. 1960; 7:685-96. PMC: 2224890. DOI: 10.1083/jcb.7.4.685. View

15.

Hirase T, Kawashima S, Wong E, Ueyama T, Rikitake Y, Tsukita S . Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J Biol Chem. 2001; 276(13):10423-31. DOI: 10.1074/jbc.M007136200. View

16.

Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S . Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol. 1997; 137(6):1393-401. PMC: 2132539. DOI: 10.1083/jcb.137.6.1393. View

17.

Lacaz-Vieira F, Jaeger M, Farshori P, Kachar B . Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing. J Membr Biol. 1999; 168(3):289-97. DOI: 10.1007/s002329900518. View

18.

Jin K, Mao X, Greenberg D . Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A. 2000; 97(18):10242-7. PMC: 27841. DOI: 10.1073/pnas.97.18.10242. View

19.

Balda M, Flores-Maldonado C, Cereijido M, Matter K . Multiple domains of occludin are involved in the regulation of paracellular permeability. J Cell Biochem. 2000; 78(1):85-96. View

20.

Saitou M, Furuse M, Sasaki H, Schulzke J, Fromm M, Takano H . Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell. 2000; 11(12):4131-42. PMC: 15062. DOI: 10.1091/mbc.11.12.4131. View